Related references
Note: Only part of the references are listed.Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism
Minh-Vu H. Nguyen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis
George R. Thompson et al.
MEDICAL MYCOLOGY (2019)
Coccidioidomycosis in Latin America
Rafael Laniado-Laborin et al.
MEDICAL MYCOLOGY (2019)
Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response
Shanjana Awasthi et al.
VACCINE (2019)
The Rise of Valley Fever: Prevalence and Cost Burden of Coccidioidomycosis Infection in California
Leslie Wilson et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever
Celine A. Hayden et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Isavuconazole in the Treatment of Coccidioidal Meningitis
Arash Heidari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental Coccidioides immitis Pneumonia
Suganya Viriyakosol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Fantastic yeasts and where to find them: the hidden diversity of dimorphic fungal pathogens
Marley C. Caballero Van Dyke et al.
CURRENT OPINION IN MICROBIOLOGY (2019)
Tolerability of long-term fluconazole therapy
Matthew R. Davis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Evaluation of Amphotericin B Lipid Formulations for Treatment of Severe Coccidioidomycosis
Ritam Sidhu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In vitro and in vivo Evaluation of APX001A/APX001 and other Gwt1 inhibitors against Cryptococcus
Karen Joy Shaw et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
John E. Edwards et al.
CLINICAL INFECTIOUS DISEASES (2018)
Myeloid Differentiation Factor 88 and Interleukin-1R1 Signaling Contribute to Resistance to Coccidioides immitis
Suganya Viriyakosol et al.
INFECTION AND IMMUNITY (2018)
Itraconazole induced hypertension and hypokalemia: Mechanistic evaluation
Wesley J. Hoffmann et al.
MYCOSES (2018)
Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity
Lisa F. Shubitz et al.
VACCINE (2018)
Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection
Chiung-Yu Hung et al.
INFECTION AND IMMUNITY (2018)
Elevated regulatory T cells at diagnosis of Coccidioides infection associates with chronicity in pediatric patients
Dan Davini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
The anti-Aspergillus drug pipeline: Is the glass half full or empty?
Nir Osherov et al.
MEDICAL MYCOLOGY (2017)
Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation
Julian Lindsay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes
Marley C. Caballero Van Dyke et al.
FRONTIERS IN IMMUNOLOGY (2017)
Antifungal resistance: current trends and future strategies to combat
Nathan P. Wiederhold
INFECTION AND DRUG RESISTANCE (2017)
In Vivo 11 β-Hydroxysteroid Dehydrogenase Inhibition in Posaconazole-Induced Hypertension and Hypokalemia
George R. Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from US Institutions
George R. Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Risk Factors for Disseminated Coccidioidomycosis, United States
Camila D. Odio et al.
EMERGING INFECTIOUS DISEASES (2017)
Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
John N. Galgiani et al.
CLINICAL INFECTIOUS DISEASES (2016)
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
George R. Thompson et al.
CLINICAL INFECTIOUS DISEASES (2016)
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Thomas F. Patterson et al.
CLINICAL INFECTIOUS DISEASES (2016)
Card9-and MyD88-Mediated Gamma Interferon and Nitric Oxide Production Is Essential for Resistance to Subcutaneous Coccidioides posadasii Infection
Chiung-Yu Hung et al.
INFECTION AND IMMUNITY (2016)
A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection
Hema P. Narra et al.
INFECTION AND IMMUNITY (2016)
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al.
LANCET (2016)
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Francisco M. Marty et al.
LANCET INFECTIOUS DISEASES (2016)
The epidemiology of fungemia in an infectious diseases hospital in Mexico city: A 10-year retrospective review
Veronica Alejandra Gaona-Flores et al.
MEDICAL MYCOLOGY (2016)
Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections
Aaron N. Pham et al.
MYCOSES (2016)
Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether -cyclodextrin in haematological patients with renal impairment
Si-Hyun Kim et al.
MYCOSES (2016)
Interactions of fungal pathogens with phagocytes
Lars P. Erwig et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
Monica A. Donnelley et al.
INFECTION AND DRUG RESISTANCE (2016)
The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas
Theo N. Kirkland
JOURNAL OF FUNGI (2016)
Role of Coccidioides Antigen Testing in the Cerebrospinal Fluid for the Diagnosis of Coccidioidal Meningitis
Christelle Kassis et al.
CLINICAL INFECTIOUS DISEASES (2015)
Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary Coccidioidomycosis
Eric R. G. Lewis et al.
EUKARYOTIC CELL (2015)
In vitro interactions between amphotericin B and hydrocortisone: potential implications for intrathecal therapy
Greg Hodge et al.
MEDICAL MYCOLOGY (2015)
Dust Devil: The Life and Times of the Fungus That Causes Valley Fever
Eric R. G. Lewis et al.
PLOS PATHOGENS (2015)
Coccidioides Endospores and Spherules Draw Strong Chemotactic, Adhesive, and Phagocytic Responses by Individual Human Neutrophils
Cheng-Yuk Lee et al.
PLOS ONE (2015)
Rates and Risk Factors for Coccidioidomycosis among Prison Inmates, California, USA, 2011
Charlotte Wheeler et al.
EMERGING INFECTIOUS DISEASES (2015)
Alopecia and Nail Changes Associated With Voriconazole Therapy
Anurag N. Malani et al.
CLINICAL INFECTIOUS DISEASES (2014)
Neither Dectin-2 nor the Mannose Receptor Is Required for Resistance to Coccidioides immitis in Mice
Suganya Viriyakosol et al.
INFECTION AND IMMUNITY (2014)
Vaccinated C57BL/6 Mice Develop Protective and Memory T Cell Responses to Coccidioides posadasii Infection in the Absence of Interleukin-10
Chiung-Yu Hung et al.
INFECTION AND IMMUNITY (2014)
Interleukin-1 Receptor but Not Toll-Like Receptor 2 Is Essential for MyD88-Dependent Th 17 Immunity to Coccidioides Infection
Chiung-Yu Hung et al.
INFECTION AND IMMUNITY (2014)
Modeling Nikkomycin Z Dosing and Pharmacology in Murine Pulmonary Coccidioidomycosis Preparatory to Phase 2 Clinical Trials
Lisa F. Shubitz et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Characteristics of Patients with Mild to Moderate Primary Pulmonary Coccidioidomycosis
Janis E. Blair et al.
EMERGING INFECTIOUS DISEASES (2014)
Amphotericin B-Impregnated Bone Cement To Treat Refractory Coccidioidal Osteomyelitis
Elizabeth S. Zhu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients
A. K. Haylett et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Coccidioidomycosis Acquired in Washington State
Nicola Marsden-Haug et al.
CLINICAL INFECTIOUS DISEASES (2013)
Pediatric Coccidioidomycosis in Central California: A Retrospective Case Series
James M. McCarty et al.
CLINICAL INFECTIOUS DISEASES (2013)
Treatment of Pediatric Refractory Coccidioidomycosis With Combination Voriconazole and Caspofungin: A Retrospective Case Series
Emily R. Levy et al.
CLINICAL INFECTIOUS DISEASES (2013)
Recent Advances in Our Understanding of the Environmental, Epidemiological, Immunological, and Clinical Dimensions of Coccidioidomycosis
Chinh Nguyen et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Immunological Characterization of Bronchoalveolar Lavage Fluid in Patients With Acute Pulmonary Coccidioidomycosis
Lance A. Nesbit et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Deep Dermatophytosis and Inherited CARD9 Deficiency
Fanny Lanternier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Itraconazole decreases left ventricular contractility in isolated rabbit heart: Mechanism of action
Yusheng Qu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Dectin-1 Is Required for Resistance to Coccidioidomycosis in Mice
Suganya Viriyakosol et al.
MBIO (2013)
Novel Strategies to Enhance Vaccine Immunity against Coccidioidomycosis
Garry T. Cole et al.
PLOS PATHOGENS (2013)
Coccidioidomycosis: epidemiology
George Thompson et al.
Clinical Epidemiology (2013)
Coccidioidomycosis-associated Hospitalizations, California, USA, 2000-2011
Gail Sondermeyer et al.
EMERGING INFECTIOUS DISEASES (2013)
Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Beyond Empiricism: Informing Vaccine Development through Innate Immunity Research
Stuart M. Levitz et al.
CELL (2012)
Dendritic Cells in Antifungal Immunity and Vaccine Design
Rene M. Roy et al.
CELL HOST & MICROBE (2012)
Construction and Evaluation of a Novel Recombinant T Cell Epitope-Based Vaccine against Coccidioidomycosis
Brady J. Hurtgen et al.
INFECTION AND IMMUNITY (2012)
Protective antifungal memory CD8+ T cells are maintained in the absence of CD4+ T cell help and cognate antigen in mice
Som G. Nanjappa et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection
Chiung-Yu Hung et al.
VACCINE (2012)
Tc17 Cells Mediate Vaccine Immunity against Lethal Fungal Pneumonia in Immune Deficient Hosts Lacking CD4+ T Cells
Som Gowda Nanjappa et al.
PLOS PATHOGENS (2012)
Progress Toward a Human Vaccine Against Coccidioidomycosis
Garry T. Cole et al.
CURRENT FUNGAL INFECTION REPORTS (2012)
In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods
Michael A. Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
Mamiko Miyazaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Interleukin-12 Receptor β1 Deficiency Predisposing to Disseminated Coccidioidomycosis
Donald C. Vinh et al.
CLINICAL INFECTIOUS DISEASES (2011)
Treatment of Refractory Coccidioidomycosis With Voriconazole or Posaconazole
Michelle M. Kim et al.
CLINICAL INFECTIOUS DISEASES (2011)
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method
Michael A. Pfaller et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Vaccine Immunity to Coccidioidomycosis Occurs by Early Activation of Three Signal Pathways of T Helper Cell Response (Th1, Th2, and Th17)
Chiung-Yu Hung et al.
INFECTION AND IMMUNITY (2011)
Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods
Michael A. Pfaller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Absence of phagocyte NADPH oxidase 2 leads to severe inflammatory response in lungs of mice infected with Coccidioides
Angel Gonzalez et al.
MICROBIAL PATHOGENESIS (2011)
Coccidioides releases a soluble factor that suppresses nitric oxide production by murine primary macrophages
Angel Gonzalez et al.
MICROBIAL PATHOGENESIS (2011)
Nitric oxide synthase activity has limited influence on the control of Coccidioides infection in mice
Angel Gonzalez et al.
MICROBIAL PATHOGENESIS (2011)
Mechanism of Voriconazole-Induced Transient Visual Disturbance: Reversible Dysfunction of Retinal ON-Bipolar Cells in Monkeys
Junzo Kinoshita et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
CD4+ T Cell Epitope Discovery and Rational Vaccine Design
Daniela Santoro Rosa et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2010)
Polyfunctional T Lymphocytes Are in the Peripheral Blood of Donors Naturally Immune to Coccidioidomycosis and Are Not Induced by Dendritic Cells
Lance Nesbit et al.
INFECTION AND IMMUNITY (2010)
Coccidioidal Meningitis Clinical Presentation and Management in the Fluconazole Era
Glenn Mathisen et al.
MEDICINE (2010)
Th17 cytokines and vaccine-induced immunity
Yinyao Lin et al.
SEMINARS IN IMMUNOPATHOLOGY (2010)
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
David Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Voriconazole Use for Endemic Fungal Infections
Alison Freifeld et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
George R. Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Comparative Efficacies of Lipid-Complexed Amphotericin B and Liposomal Amphotericin B against Coccidioidal Meningitis in Rabbits
Karl V. Clemons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis
M. Reinwald et al.
BONE MARROW TRANSPLANTATION (2009)
Efficacy of a Genetically Engineered Candida albicans tet-NRG1 Strain as an Experimental Live Attenuated Vaccine against Hematogenously Disseminated Candidiasis
Stephen P. Saville et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Refractory Disseminated Coccidioidomycosis and Mycobacteriosis in Interferon-γ Receptor 1 Deficiency
Donald C. Vinh et al.
CLINICAL INFECTIOUS DISEASES (2009)
A Genetically Engineered Live Attenuated Vaccine of Coccidioides posadasii Protects BALB/c Mice against Coccidioidomycosis
Jianmin Xue et al.
INFECTION AND IMMUNITY (2009)
Mannose-Binding Lectin Serum Levels are Low in Persons with Clinically Active Coccidioidomycosis
Neil M. Ampel et al.
MYCOPATHOLOGIA (2009)
Human Dectin-1 Deficiency and Mucocutaneous Fungal Infections
Bart Ferwerda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Insights into the Mechanisms of Protective Immunity against Cryptococcus neoformans Infection Using a Mouse Model of Pulmonary Cryptococcosis
Karen L. Wozniak et al.
PLOS ONE (2009)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2008)
Susceptibility to Coccidioides species in C57BL/6 mice is associated with expression of a truncated splice variant of Dectin-1 (Clec7a)
M. del Pilar Jimenez-A et al.
GENES AND IMMUNITY (2008)
Posaconazole concentrations in the central nervous system
Maria J. G. T. Rueping et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Vaccines to prevent systemic mycoses: Holy grails meet translational realities
John N. Galgiani
JOURNAL OF INFECTIOUS DISEASES (2008)
Role of particle size in phagocytosis of polymeric microspheres
Julie A. Champion et al.
PHARMACEUTICAL RESEARCH (2008)
Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis
Roger A. Herr et al.
INFECTION AND IMMUNITY (2007)
Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model
Gloria M. Gonzalez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis
Antonino Catanzaro et al.
CLINICAL INFECTIOUS DISEASES (2007)
Posaconazole therapy for chronic refractory coccidioidomycosis
David A. Stevens et al.
CHEST (2007)
Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis
Perparim Kamberi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain
Floyd L. Wormley et al.
INFECTION AND IMMUNITY (2007)
A comparison of the pulmonary inflammatory potential of different components of yeast cell wall
Shih-Houng Young et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2007)
Multivalent recombinant protein vaccine against coccidioidomycosis
Eric J. Tarcha et al.
INFECTION AND IMMUNITY (2006)
Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein
Lisa F. Shubitz et al.
VACCINE (2006)
Mechanics of neutrophil phagocytosis: experiments and quantitative models
Marc Herant et al.
JOURNAL OF CELL SCIENCE (2006)
Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice
J Fierer et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate
KI Orsborn et al.
INFECTION AND IMMUNITY (2006)
Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1
EJ Yeo et al.
BLOOD (2006)
A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice
EJ Tarcha et al.
INFECTION AND IMMUNITY (2006)
Coccidioidomycosis in hematopoietic stem cell transplant recipients
TJ Glenn et al.
MEDICAL MYCOLOGY (2005)
Role of B cells in vaccine-induced immunity against coccidioidomycosis
DM Magee et al.
INFECTION AND IMMUNITY (2005)
A metalloproteinase of Coccidioides posadasii contributes to evasion of host detection
CY Hung et al.
INFECTION AND IMMUNITY (2005)
Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii
S Awasthi et al.
JOURNAL OF IMMUNOLOGY (2005)
Refractory coccidioidomycosis treated with posaconazole
GM Anstead et al.
CLINICAL INFECTIOUS DISEASES (2005)
Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection
JM Xue et al.
VACCINE (2005)
Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on toll-like receptor 2 and dectin-1
S Viriyakosol et al.
INFECTION AND IMMUNITY (2005)
Differences in expression of cell surface co-stimulatory molecules, Toll-like receptor genes and secretion of IL-12 by bone marrow-derived dendritic cells from susceptible and resistant mouse strains in response to Coccidioides posadasii
S Awasthi et al.
CELLULAR IMMUNOLOGY (2004)
Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis
GM González et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
A vaccine against coccidioidomycosis is justified and attainable
GT Cole et al.
MEDICAL MYCOLOGY (2004)
Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells:: Implications for vaccine development in immune-deficient hosts
M Wüthrich et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Triad of acute infusion-related reactions associated with liposomal amphotericin B: Analysis of clinical and epidemiological characteristics
MM Roden et al.
CLINICAL INFECTIOUS DISEASES (2003)
A novel class of gene controlling virulence in plant pathogenic ascomycete fungi
SW Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis
JO Richards et al.
JOURNAL OF IMMUNOLOGY (2002)
Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits
KV Clemons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis
CY Jiang et al.
INFECTION AND IMMUNITY (2002)
A parasitic phase-specific adhesin of Coccidioides immitis contributes to the virulence of this respiratory fungal pathogen
CY Hung et al.
INFECTION AND IMMUNITY (2002)
In vitro and in vivo activities of posaconazole against Coccidioides immitis
GM González et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation
JO Richards et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Biogeographic range expansion into South America by Coccidioides immitis mirrors New World patterns of human migration
MC Fisher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis - A randomized, double-blind trial
JN Galgiani et al.
ANNALS OF INTERNAL MEDICINE (2000)
Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis
KN Sorensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses
CY Hung et al.
INFECTION AND IMMUNITY (2000)
Share Paper
